• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . A Strategic Framework of SARS-CoV-2 Genomic Surveillance in Bangladesh

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Oct;18(10):e70019.
doi: 10.1111/irv.70019. A Strategic Framework of SARS-CoV-2 Genomic Surveillance in Bangladesh

Mohammad Jubair[SUP] 1 [/SUP], Md Mobarok Hossain[SUP] 1 [/SUP], Mst Noorjahan Begum[SUP] 2 [/SUP], Shovan Basak Moon[SUP] 1 [/SUP], Shahriar Islam[SUP] 1 [/SUP], Md Yeasir Karim[SUP] 2 [/SUP], Sezanur Rahman[SUP] 2 [/SUP], Manjur H Khan[SUP] 3 [/SUP], Mohammad Tanbir Habib[SUP] 4 [/SUP], Tahmina Shirin[SUP] 3 [/SUP], Firdausi Qadri[SUP] 2 4 [/SUP], Mustafizur Rahman[SUP] 1 2 [/SUP]



Affiliations
Abstract

Background: The global pandemic caused by SARS-CoV-2 has underlined the significance of strict genomic surveillance to track virus evolution and the possible emergence of new variants, particularly in densely populated countries like Bangladesh. This study outlines a strategic framework of genomic surveillance to track the evolution of the virus in Bangladesh between June 2021 and December 2022 through the National SARS-CoV-2 Variant Surveillance (NSVS) program involving collaboration across 4 major institutes and 13 hospitals nationwide.
Methods: We aimed to capture the variants of SARS-CoV-2 throughout the country utilizing standardized procedures, modern sequencing technology, and stringent quality control, promoting data accuracy and the timely detection of new variants of concern. We sequenced over 2200 genomes, documenting the prevalence of the Delta variant initially, followed by the emergence of Omicron variants BA.1, BA.2, BA.5, and XBB, each affecting transmission rates and vaccine efficacy differently.
Results: The clinical manifestations of the variants differed, with some symptoms occurring more frequently in Delta cases and vice versa. Vaccinated individuals were more affected by Omicron cases compared to Delta cases. These variants were responsible for two major COVID-19 waves in the country, each with significant clinical effects. Phylogenetic analyses placed the local SARS-CoV-2 variants within a global context, indicating the Delta variant likely entered from India and Omicron from Europe.
Conclusion: This research highlights the significance of collaborative surveillance strategies for guiding public health choices and the critical role of genomic analysis in monitoring virus evolution, shaping targeted pandemic responses. Bangladesh's contributions significantly enhance global insight into COVID-19's genomic evolution.

Keywords: Bangladesh; COVID‐19; Delta; Omicron; SARS‐CoV‐2; surveillance.

 
Back
Top Bottom